(TLSA) Tiziana Life Sciences - Performance 145.3% in 12m
Compare TLSA with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-24.83%
#44 in Group
Rel. Strength
94.44%
#443 in Universe
Total Return 12m
145.26%
#15 in Group
Total Return 5y
-25.81%
#39 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -10.56%
(?) Percentile in Group
12m Total Return: TLSA (145.3%) vs XBI (-11.5%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
9.32% | 17.6% | 174% | 12.4 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
7.15% | 32% | 48.9% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-6.52% | -8.21% | 34.6% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
8.27% | 11.5% | 33.2% | 65.7 | 36 | 1.31 | 2.20% | -12.5% |
BIM PA Biomerieux |
2.35% | 22.3% | -1.74% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
NBIX NASDAQ Neurocrine Biosciences |
26.9% | -11.6% | 7.86% | 39.2 | 23.6 | 0.27 | 18.7% | -34.3% |
KMDA NASDAQ Kamada |
8.6% | 26% | -5.07% | 27.5 | 25.1 | 1 | 32.5% | 3.93% |
ERF PA Eurofins Scientific SE |
14.1% | 0.03% | 8.57% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: TLSA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for TLSA
Total Return (including Dividends) | TLSA | XBI | S&P 500 |
---|---|---|---|
1 Month | 87.48% | 3.80% | 8.14% |
3 Months | 100.53% | -11.69% | -3.09% |
12 Months | 145.26% | -11.47% | 13.34% |
5 Years | -25.81% | -19.52% | 120.03% |
Trend Score (consistency of price movement) | TLSA | XBI | S&P 500 |
1 Month | 85.7% | 48.1% | 90.1% |
3 Months | 32.9% | -81% | -66.3% |
12 Months | 22.5% | -54.5% | 48.9% |
5 Years | -62.5% | -53.8% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #62 | 80.6% | 73.4% |
3 Month | #5 | 127% | 107% |
12 Month | #14 | 177% | 116% |
5 Years | #39 | -7.82% | -66.3% |
FAQs
Does TLSA Tiziana Life Sciences outperforms the market?
Yes,
over the last 12 months TLSA made 145.26%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.47%.
Over the last 3 months TLSA made 100.53%, while XBI made -11.69%.
Over the last 3 months TLSA made 100.53%, while XBI made -11.69%.
Performance Comparison TLSA vs Indeces and Sectors
TLSA vs. Indices TLSA is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 19.5% | 79.3% | 61.3% | 132% |
US NASDAQ 100 | QQQ | 18.4% | 76.5% | 60.3% | 130% |
US Dow Jones Industrial 30 | DIA | 20.1% | 82.8% | 62.3% | 136% |
German DAX 40 | DAX | 22.0% | 75.2% | 36.1% | 120% |
Shanghai Shenzhen CSI 300 | CSI 300 | 20.0% | 81.8% | 61.4% | 136% |
Hongkong Hang Seng | HSI | 17.9% | 73.1% | 50.3% | 135% |
India NIFTY 50 | INDA | 23.0% | 81.0% | 57.9% | 139% |
Brasil Bovespa | EWZ | 20.0% | 77.6% | 55.7% | 152% |
TLSA vs. Sectors TLSA is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 21.4% | 79.5% | 56.9% | 122% |
Consumer Discretionary | XLY | 16.3% | 75.8% | 61.0% | 125% |
Consumer Staples | XLP | 23.5% | 88.3% | 57.8% | 138% |
Energy | XLE | 17.9% | 80.7% | 67.9% | 152% |
Financial | XLF | 20.1% | 79.6% | 56.5% | 121% |
Health Care | XLV | 24.5% | 89.3% | 66.4% | 149% |
Industrial | XLI | 18.8% | 77.0% | 59.9% | 131% |
Materials | XLB | 20.3% | 81.3% | 65.1% | 149% |
Real Estate | XLRE | 23.5% | 82.8% | 61.0% | 132% |
Technology | XLK | 17.3% | 73.7% | 62.8% | 134% |
Utilities | XLU | 22.7% | 84.8% | 56.4% | 130% |
Aerospace & Defense | XAR | 21.0% | 77.6% | 52.6% | 117% |
Biotech | XBI | 26.8% | 83.7% | 80.5% | 157% |
Homebuilder | XHB | 18.5% | 77.6% | 72.3% | 150% |
Retail | XRT | 16.8% | 75.8% | 65.0% | 146% |